Alyeska Investment Group, L.P. Ultragenyx Pharmaceutical Inc. Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,429,437 shares of RARE stock, worth $49.2 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,429,437
Previous 1,495,351
4.41%
Holding current value
$49.2 Million
Previous $54.1 Million
4.01%
% of portfolio
0.2%
Previous 0.23%
Shares
5 transactions
Others Institutions Holding RARE
# of Institutions
361Shares Held
88.3MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$351 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$193 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$136 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$99.3 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$95.4 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.41B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...